Brief introduction of Nanjing Zhongshan pharmaceutical co., ltd

The company passed GMP certification for the first time in May 2003, and passed GMP re-certification in March 2008. The company adheres to the innovative strategies of "combining technological innovation with digestion and absorption", "combining technological innovation with secondary development" and "combining technological innovation with intellectual property rights", and pays attention to the application of modern advanced technologies such as supercritical fluid extraction technology, ultrafine grinding technology and β -cyclodextrin inclusion technology, so as to continuously enhance the technical connotation of traditional Chinese medicine and enhance the core competitiveness of products.

The company vigorously promotes informatization to drive industrialization development, and the "ERP system with GMP management concept" cooperated with Jiangsu Jinsiwei Technology Company has been running stably in production.

The company has 2 national protected varieties of traditional Chinese medicine, 3 national key new products, 8 new drug certificates, 5 varieties under research, 6 high-tech products in Nanjing and 5 excellent new products, and has obtained patents 1 1, including 9 invention patents and 2 design patents. It has successively undertaken the National 863 Project, the National New Drug Fund Project, the National Torch Program Project, Jiangsu Province and Nanjing.

"Mochou" trademark won the title of famous trademark in Nanjing, and Xu Anqi Tongbi capsule and its preparation technology patent won the top ten outstanding patents in Nanjing and the first prize of scientific and technological progress in Yuhua District. At the same time, the company attaches great importance to the combination of Industry-University-Research, and has successively become the master training point of Yanbian University and the internship base of Nanjing Normal University, with 9 graduate students and more than 20 undergraduates.